Type	Name	Date
Indenture	Indenture, by and between Sarepta Therapeutics, Inc. and U. S. Bank Trust Company, National Association (including the form of the 1.250% Convertible Senior Note due 2027)	09/19/2022
Underwriting agreement	Underwriting Agreement, among Sarepta Therapeutics, Inc. and Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC and Credit Suisse Securities (USA) LLC, as representatives of the underwriters named therein	11/09/2018
Underwriting agreement	Underwriting Agreement, among Sarepta Therapeutics, Inc. and Goldman, Sachs & Co. LLC and J.P. Morgan Securities LLC, as representatives of the underwriters named therein	07/26/2017
Underwriting agreement	Underwriting Agreement, among Sarepta Therapeutics, Inc. and J.P. Morgan Securities LLC and Goldman, Sachs & Co., as representatives of the underwriters named therein	09/23/2016
Underwriting agreement	Underwriting Agreement, among Sarepta Therapeutics, Inc. and J.P. Morgan Securities LLC and Goldman, Sachs & Co., as representatives of the underwriters named therein	09/23/2016
Underwriting agreement	Underwriting Agreement, among Sarepta Therapeutics, Inc. and Credit Suisse Securities (USA) LLC and Morgan Stanley & Co. LLC, as representatives of the underwriters named therein	10/06/2015
Underwriting agreement	Underwriting Agreement, among Sarepta Therapeutics, Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated and Morgan Stanley & Co. LLC, as representatives of the underwriters named therein	04/24/2014
Underwriting agreement	Underwriting Agreement, among Sarepta Therapeutics, Inc., Lazard Capital Markets LLC, and Cowen and Company, LLC, as representatives of the underwriters named therein	12/18/2012